Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.310
-0.030 (-2.24%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $452.59 million as of October 16, 2026. It is the 15,386th most valuable company in the world and the 2,802nd biggest in the United States. Its market cap has increased by 60.61% in one year.
Market Cap
452.59M
Enterprise Value
199.00M
1-Year Change
60.61%
Global Rank
Country Rank
#2,802 United States
Category
ChartMarket Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.84B to $452.59M, a decrease of -84.08%. That is a compound annual growth rate of -20.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 452.60M | 47.00% |
| Dec 31, 2025 | 307.90M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.33% |
| Dec 29, 2023 | 540.20M | -40.45% |
| Dec 30, 2022 | 907.10M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | 3.54B | 11.80% |
| Dec 31, 2019 | 3.17B | -3.19% |
| Dec 31, 2018 | 3.27B | 15.10% |
| Oct 11, 2018 | 2.84B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Entera Bio | 466.11M |
| Neurogene | 465.26M |
| Monopar Therapeutics | 464.95M |
| REGENXBIO | 457.14M |
| Arvinas | 455.74M |
| Oculis Holding AG | 450.03M |
| BlossomHill Therapeutics | 443.08M |
| Eupraxia Pharmaceuticals | 435.64M |